| abstract |
The present invention provides isolated nucleic acid molecules and purified c-keytrigand (KL) polypeptides or soluble fragments thereof that encode an amino acid sequence corresponding to a c-kit ligand (KL). The present invention also administers to a patient a pharmaceutical composition comprising a c-kit ligand (KL) purified by the applicant or produced by the applicant's recombinant method and a pharmaceutically acceptable carrier and a pharmaceutical composition of the invention. It provides a treatment method of a patient in particular. |